Video

Riad Sherif, CEO of Oculis, gives a company update on clinical trials, financing and other items in the pipeline

Author(s):

Kassi Jackson
Conferences|ASCRS

Riad Sherif, MD, CEO of Oculis, gives a company update on clinical trials for products in DME, ocular surgery, and more; plus, growing products in glaucoma treatments, team and financing updates.

Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Vikas Chopra, MD, at AAO 2024: The role of MIGS in earlier intervention and safer techniques
Related Content
USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy
November 21st 2024

USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

FDA accepts NDA from Aldeyra Therapeutics for reproxalap for dry eye
November 19th 2024

FDA accepts NDA from Aldeyra Therapeutics for reproxalap for dry eye

Robert Chang, MD, discusses the impact of large language models on glaucoma care and AI in ophthalmology
November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

Ocugen announces positive preliminary data from OCU410 Phase 1 clinical trial for geographic atrophy
November 19th 2024

Ocugen announces positive preliminary data from OCU410 Phase 1 clinical trial for geographic atrophy

Binocular amblyopia home treatment: The next step after patching
November 19th 2024

Binocular amblyopia home treatment: The next step after patching

© 2024 MJH Life Sciences

All rights reserved.